A case of fulminant neuroleptic malignant syndrome with COVID-19
Journal of Geriatric Neurology · 2022
DOI: 10.53991/jgn.2022.00073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Geriatric Neurology, 2022. Verfasst von Dong Hyun Kim und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Neuroleptic malignant syndrome (NMS) is a life-threatening neuropsychiatric emergency mani-festing hyperpyrexia, rigidity, altered consciousness, and autonomic instability [1]. NMS is associated with the administration of D 2 dopamine receptor-blocking antipsychotics or abrupt discontinua-tion of antiparkinsonian drugs [1]. Although the pathophysiology of NMS is mainly considered acute interruptions of dopaminergic transmission in the basal ganglia and hypothalamus, but there are several risk factors contributing to the development of NMS, including dehydration, agitation, organic brain disorders, and concomitant medical illness [1]. During the ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), various neurological manifestations and complications of COVID-19 have been reported, ranging from headache, anosmia and ageusia to cerebrovascular disease, seizure, and enceph-alopathy [2]. However, there are few reports of NMS accompanying the acute
Zitieren
APA
Kim, D. H., Choi, M. G., Kim, J., Kim, H. Y., & Lee, S. H. (2022). A case of fulminant neuroleptic malignant syndrome with COVID-19. Journal of Geriatric Neurology. https://doi.org/10.53991/jgn.2022.00073
Vancouver
Kim DH, Choi MG, Kim J, Kim HY, Lee SH. A case of fulminant neuroleptic malignant syndrome with COVID-19. Journal of Geriatric Neurology. 2022. doi:10.53991/jgn.2022.00073
BibTeX
@article{Kim2022,
author = {Kim, Dong Hyun and Choi, Moon Gwan and Kim, Jae-Woo and Kim, Hye Yun and Lee, Seung Hyun},
title = {A case of fulminant neuroleptic malignant syndrome with COVID-19},
journal = {Journal of Geriatric Neurology},
year = {2022},
doi = {10.53991/jgn.2022.00073}
}
EUVIMED